Finding the “Missing 50%” of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Blood cultures are limited for diagnosing invasive candidiasis by poor sensitivity and slow turn-around time. New diagnostics are needed to complement cultures, in particular to identify the "missing 50%" of patients who are blood culture-negative. Mannan/anti-mannan immunoglobulin G, β-D-glucan (BDG) and polymerase chain reaction (PCR) assays can diagnose candidemia before blood cultures and show promising sensitivity/specificity, but they are not widely investigated in blood culture-negative, deep-seated candidiasis. In a recent study, BDG and PCR were superior to blood cultures in deep-seated candidiasis, suggesting they may identify currently undiagnosed patients and expand our understanding of disease spectrum. Positive predictive values of nonculture tests are limited by the low prevalence of invasive candidiasis, which mandates that results be interpreted judiciously. When used as biomarkers that assess a patient's risk of having invasive candidiasis, tests will facilitate preemptive antifungal strategies. Because negative predictive values are excellent, tests will also be useful for ruling out invasive candidiasis and discontinuing unnecessary antifungal therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Blood cultures, however, are positive in only 21–71% of patients later proven by autopsy to have IC.16”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [16]
In the citing paper
“In concert, this data has led to the conclusion that the sensitivity for blood cultures for invasive candidiasis is only 50%.16”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [16]
In the citing paper
“However, blood cultures cannot be relied upon in all cases of IC given approximately one-third of patients with IC are categorized as having deep-seated infection without candidemia.16”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [16]
In the citing paper
“Previous studies of autopsy-proven invasive candidiasis suggest that blood cultures are positive in 21%-71% of cases [9], which suggests that the estimated burden of invasive candidiasis would be even higher, although further evaluation of the relative burden of candidemia in overall invasive candidiasis is needed.”
From Burden of Candidemia in the United States, 2017 (2020) · cites this paper as [9]
In the citing paper
“StC events could have been missed because of missed screening opportunities, the insensitivity of culture (9), treating clinical laboratories that might not routinely distinguish C. auris from other Candida species for nonsterile specimen types (10), and the fact that US C. auris data from 2024 are not finalized, meaning some patients might not have had sufficient lead time for clinical cases to”
From Progression from Candida auris Colonization Screening to Clinical Case Status, United States, 2016–2023 (2025) · cites this paper as [9]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Bouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183
Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis021 · Cited by 793
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
Hong Nguyen, M., Peacock, J. E., Morris, A. J., Tanner, D. C., Nguyen, M. L., Snydman, D. R., Wagener, M. M., Rinaldi, M. G., & Yu, V. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(95)00010-0 · Cited by 758
Self-citation-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Karageorgopoulos, D. E., Vouloumanou, E. K., Ntziora, F., Michalopoulos, A., Rafailidis, P. I., & Falagas, M. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq206 · Cited by 538
Leroy, O., Gangneux, J.-P., Montravers, P., Mira, J.-P., Gouin, F., Sollet, J.-P., Carlet, J., Reynes, J., Rosenheim, M., Regnier, B., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819efac0 · Cited by 535
Hepatic Candidiasis in Cancer Patients: The Evolving Picture of the Syndrome
THALER, M., PASTAKIA, B., SHAWKER, T. H., O'LEARY, T., & PIZZO, P. A. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-1-88 · Cited by 395
PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis
Avni, T., Leibovici, L., & Paul, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01602-10 · Cited by 389
Ostrosky-Zeichner, L., Sable, C., Sobel, J., Alexander, B. D., Donowitz, G., Kan, V., Kauffman, C. A., Kett, D., Larsen, R. A., Morrison, V., et al. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0270-z · Cited by 369
Mikulska, M., Calandra, T., Sanguinetti, M., Poulain, D., Viscoli, C., & the Third European Conference on Infections in Leukemia Group (2010) · Critical Care · doi:10.1186/cc9365 · Cited by 319 · cited 2×
“Values for the combined assay were 83% and 86%, with best performances for C. albicans , C. glab-rata , and Candida tropicalis infections [17].”
Result
Research works printed but not linked: 1
- Nguyen MH Clancy CJ . Washington, DC: American Society for Microbiology; 2012. Intra-abdominal candidiasis (IAC) Is under-recognized, but is the most common yype of invasive candidiasis (IC) and results in poor outcomes [abstract M1685]; p. 164. Program and abstracts of the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco.
Cited by
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
“sive candidiasis is roughly 50% [20].”
BackgroundInfluentialSelf-citationGlobal and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.26 · Cited by 1,636
Kullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315
Tackling the emerging threat of antifungal resistance to human health
Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00720-1 · Cited by 1,179
T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial
Mylonakis, E., Clancy, C. J., Ostrosky-Zeichner, L., Garey, K. W., Alangaden, G. J., Vazquez, J. A., Groeger, J. S., Judson, M. A., Vinagre, Y.-M., Heard, S. O., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu959 · Cited by 443
“The commercially available (1,3)-β-D-glucan assay is not specific for Candida, and high rates of false-positive results in high-risk populations have been reported [11].”
Self-citationPfaller, M. A., Andes, D. R., Diekema, D. J., Horn, D. L., Reboli, A. C., Rotstein, C., Franks, B., & Azie, N. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101510 · Cited by 396
“The use of non-culture tests as biomarkers may prove to be useful adjuncts to blood culture, and identify some patients who are currently undiagnosed [68].”
BackgroundInvasive candidiasis as a cause of sepsis in the critically ill patient
Delaloye, J., & Calandra, T. (2014) · Virulence · doi:10.4161/viru.26187 · Cited by 372
The Changing Epidemiology of Invasive Fungal Infections
Enoch, D. A., Yang, H., Aliyu, S. H., & Micallef, C. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6515-1_2 · Cited by 370
“The three main types of invasive disease are: (1) Majocchi’s granuloma, a nodular infi ltrative folliculitis that is self-limiting in immunocompetent individuals but can progress to more extensive lesions in the immunocompromised; (2) more invasive dermatophytosis following minor trauma or topical steroid use and invo…”
BackgroundMolecular and Nonmolecular Diagnostic Methods for Invasive Fungal Infections
Arvanitis, M., Anagnostou, T., Fuchs, B. B., Caliendo, A. M., & Mylonakis, E. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00091-13 · Cited by 353
“Similar to the case for invasive aspergillosis, the excellent negative predictive values of both these tests could prove to be particularly useful in the development of diagnostic algorithms for invasive candidiasis that could help to reduce the rate of unnecessary empirical antifungal therapy (210).”
Resultde Oliveira Santos, G. C., Vasconcelos, C. C., Lopes, A. J. O., de Sousa Cartágenes, M. D. S., Filho, A. K. D. B., do Nascimento, F. R. F., Ramos, R. M., Pires, E. R. R. B., de Andrade, M. S., Rocha, F. M. G., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01351 · Cited by 350
Bassetti, M., Azoulay, E., Kullberg, B.-J., Ruhnke, M., Shoham, S., Vazquez, J., Giacobbe, D. R., & Calandra, T. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1751 · Cited by 327
“Three entities must be considered: (1) candidemia in the absence of deep-seated candidiasis (including catheter-associated candidemia), (2) candidemia associated with deep-seated candidiasis, and (3) deep-seated candidiasis not associated with candidemia [15].”
BackgroundDadar, M., Tiwari, R., Karthik, K., Chakraborty, S., Shahali, Y., & Dhama, K. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.02.028 · Cited by 332
Diagnosing invasive candidiasis
Clancy, C. J., & Nguyen, M. H. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01909-17 · Cited by 293
“Cultures of material collected from deep sites of infection are also only 50% sensitive, likely reflecting small sample volumes and uneven distribution and low burdens of Candida cells (3).”
BackgroundInfluentialSelf-citationMcCarty, T. P., & Pappas, P. G. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.013 · Cited by 285
“The development of reliable nonculture assays is critical to providing the opportunity for earlier intervention with more targeted antifungal therapy among large numbers of at-risk patients.(18)”
BackgroundCandidemia and Invasive Candidiasis
McCarty, T. P., White, C. M., & Pappas, P. G. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.007 · Cited by 260
“22 Data from several retrospective studies suggest that early and effective treatment confers a survival benefit from candida sepsis.”
Candidemia and invasive candidiasis in adults: A narrative review
Antinori, S., Milazzo, L., Sollima, S., Galli, M., & Corbellino, M. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.06.029 · Cited by 257
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients
Martin-Loeches, I., Antonelli, M., Cuenca-Estrella, M., Dimopoulos, G., Einav, S., De Waele, J. J., Garnacho-Montero, J., Kanj, S. S., Machado, F. R., Montravers, P., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05599-w · Cited by 235
Schmiedel, Y., & Zimmerli, S. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14281 · Cited by 218
Molecular diagnosis of sepsis: New aspects and recent developments
Liesenfeld, O., Lehman, L., Hunfeld, K.-P., & Kost, G. (2014) · European Journal of Microbiology and Immunology · doi:10.1556/eujmi.4.2014.1.1 · Cited by 216
“Clancy CJ, Nguyen MH: Finding the “missing 50%” of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care.”
BackgroundBassetti, M., Giacobbe, D. R., Agvald-Ohman, C., Akova, M., Alastruey-Izquierdo, A., Arikan-Akdagli, S., Azoulay, E., Blot, S., Cornely, O. A., Cuenca-Estrella, M., et al. (2024) · Intensive Care Medicine · doi:10.1007/s00134-024-07341-7 · Cited by 205
“The most common form of deep-seated candidiasis in non-neutropenic, critically ill patients in the ICU is intra-abdominal candidiasis (IAC) [6, 8, 31, 39].”
BackgroundInvasive candidiasis: current clinical challenges and unmet needs in adult populations
Soriano, A., Honore, P. M., Puerta-Alcalde, P., Garcia-Vidal, C., Pagotto, A., Gonçalves-Bradley, D. C., & Verweij, P. E. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad139 · Cited by 190
Multimodality Imaging of Liver Infections: Differential Diagnosis and Potential Pitfalls
Bächler, P., Baladron, M. J., Menias, C., Beddings, I., Loch, R., Zalaquett, E., Vargas, M., Connolly, S., Bhalla, S., & Huete, Á. (2016) · RadioGraphics · doi:10.1148/rg.2016150196 · Cited by 183
Intensive care medicine research agenda on invasive fungal infection in critically ill patients
Bassetti, M., Garnacho-Montero, J., Calandra, T., Kullberg, B., Dimopoulos, G., Azoulay, E., Chakrabarti, A., Kett, D., Leon, C., Ostrosky-Zeichner, L., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4731-2 · Cited by 183
“Blood cultures are insensitive and take several days to obtain Candida species and antifungal susceptibilities [11].”
BackgroundDiagnosis and Treatment of Invasive Candidiasis
Barantsevich, N., & Barantsevich, E. (2022) · Antibiotics · doi:10.3390/antibiotics11060718 · Cited by 178
“are isolated from blood in only 21–71% of patients with autopsy-proven invasive candidiasis [68].”
BackgroundCandida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework
Jabra-Rizk, M. A., Kong, E. F., Tsui, C., Nguyen, M. H., Clancy, C. J., Fidel, P. L., & Noverr, M. (2016) · Infection and Immunity · doi:10.1128/iai.00469-16 · Cited by 182
“More importantly, the sensitivity of blood cultures, the current diagnostic gold standard, is only 50% (55).”
BackgroundSelf-citationInvasive candidiasis in critical care: challenges and future directions
Logan, C., Martin-Loeches, I., & Bicanic, T. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06240-x · Cited by 180
Colombo, A. L., de Almeida Júnior, J. N., Slavin, M. A., Chen, S. C.-A., & Sorrell, T. C. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30304-3 · Cited by 173
Best Practices of Blood Cultures in Low- and Middle-Income Countries
Ombelet, S., Barbé, B., Affolabi, D., Ronat, J.-B., Lompo, P., Lunguya, O., Jacobs, J., & Hardy, L. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00131 · Cited by 175
A New Age in Molecular Diagnostics for Invasive Fungal Disease: Are We Ready?
Kidd, S. E., Chen, S. C.-A., Meyer, W., & Halliday, C. L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02903 · Cited by 166
Burden of Candidemia in the United States, 2017
Tsay, S. V., Mu, Y., Williams, S., Epson, E., Nadle, J., Bamberg, W. M., Barter, D. M., Johnston, H. L., Farley, M. M., Harb, S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa193 · Cited by 163
Clancy, C. J., Pappas, P. G., Vazquez, J., Judson, M. A., Kontoyiannis, D. P., Thompson, G. R., Garey, K. W., Reboli, A., Greenberg, R. N., Apewokin, S., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1095 · Cited by 165
“The serum Fungitell assay (Associates of Cape Cod, East Falmouth, Massachusetts) detects β-D-glucan from fungal cell walls, but the test is not specific for Candida and it is limited by false positivity in patients at increased risk of candidiasis [1, 5].”
BackgroundInfluentialSelf-citationManagement of bacterial and fungal infections in cirrhosis: The MDRO challenge
Fernández, J., Piano, S., Bartoletti, M., & Wey, E. Q. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.010 · Cited by 161
Nami, S., Aghebati-Maleki, A., Morovati, H., & Aghebati-Maleki, L. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.009 · Cited by 160
Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis
Pfaller, M. A., & Castanheira, M. (2015) · Medical Mycology · doi:10.1093/mmy/myv076 · Cited by 161
“Notably, in a review of 415 autopsy-proven cases of candidiasis, Clancy and Nguyen [58] demonstrated that BCs were positive in only 38% of cases.”
BackgroundMethodInfluentialCulture-independent detection systems for bloodstream infection
Peri, A. M., Harris, P. N. A., & Paterson, D. L. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.09.039 · Cited by 172
T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis
Pfaller, M. A., Wolk, D. M., & Lowery, T. J. (2016) · Future Microbiology · doi:10.2217/fmb.15.111 · Cited by 157
Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment
Vergidis, P., Clancy, C. J., Shields, R. K., Park, S. Y., Wildfeuer, B. N., Simmons, R. L., & Nguyen, M. H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153247 · Cited by 150
“Invasive candidiasis comprises candidemia and deepseated candidiasis [1, 2].”
BackgroundSelf-citationRecent trends in molecular diagnostics of yeast infections: from PCR to NGS
Consortium OPATHY, Arastehfar, A., Boekhout, T., Butler, G., De Cesare, G. B., Dolk, E., Gabaldón, T., Hafez, A., Hube, B., Hagen, F., et al. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz015 · Cited by 131
Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002-20121
Strollo, S., Lionakis, M. S., Adjemian, J., Steiner, C. A., & Prevots, D. R. (2016) · Emerging Infectious Diseases · doi:10.3201/eid2301.161198 · Cited by 129
“Thus, patients would not be coded as having candidemia, which would lead to underestimation of illness and death (23).”
BackgroundDiagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy
Calandra, T., Roberts, J. A., Antonelli, M. M., Bassetti, M., & Vincent, J. (2016) · Critical Care · doi:10.1186/s13054-016-1313-6 · Cited by 144
“AUC: Area under the concentration–time curve; BDG: β-D-Glucan; BSI: Bloodstream infections; Cmax: maximum concentration in a dosing interval; MIC: minimum inhibitory concentration; PD: Pharmacodynamics; PK: Pharmacokinetics; RRT: renal replacement therapy; TDM: therapeutic drug monitoring.”
BackgroundInfluentialAntifungal stewardship considerations for adults and pediatrics
Hamdy, R. F., Zaoutis, T. E., & Seo, S. K. (2016) · Virulence · doi:10.1080/21505594.2016.1226721 · Cited by 132
“While the gold standard is blood culture, the overall sensitivity has been reported to be 50%.(48) In addition, the median time-to-”
BackgroundMethodFungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management
Thompson, G. R., Jenks, J. D., Baddley, J. W., Lewis, J. S., Egger, M., Schwartz, I. S., Boyer, J., Patterson, T. F., Chen, S. C. ‐., Pappas, P. G., et al. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-23 · Cited by 165
Diagnosis and treatment of invasive fungal infections: looking ahead
Sanguinetti, M., Posteraro, B., Beigelman‐Aubry, C., Lamoth, F., Dunet, V., Slavin, M. A., & Richardson, M. D. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz041 · Cited by 130
Treatment of Invasive Candidiasis: A Narrative Review
Ben-Ami, R. (2018) · Journal of Fungi · doi:10.3390/jof4030097 · Cited by 111
The Cava Trem Study Group, León, C., Ruiz-Santana, S., Saavedra, P., Castro, C., Loza, A., Zakariya, I., Úbeda, A., Parra, M., Macías, D., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1324-3 · Cited by 110
“The use of single or combined biomarkers, such as (1→ 3)-ß-D-glucan (BDG), Candida albicans germ tube antibody (CAGTA), mannan antigen (mannan-Ag), anti-mannan antibodies (mannan-Ab), and polymerase chain reaction (PCR) detection of Candida DNA has received increasing attention [7–10], but the appropriate incorporatio…”
BackgroundThe Mycobiome in Health and Disease: Emerging Concepts, Methodologies and Challenges
Tiew, P. Y., Aogáin, M. M., Ali, N. A. B. M., Thng, K. X., Goh, K., Lau, K. J. X., & Chotirmall, S. H. (2020) · Mycopathologia · doi:10.1007/s11046-019-00413-z · Cited by 138
Prevalence of biofilms in Candida spp. bloodstream infections: A meta-analysis
Atiencia-Carrera, M. B., Cabezas-Mera, F. S., Tejera, E., & Machado, A. (2022) · PLOS ONE · doi:10.1371/journal.pone.0263522 · Cited by 107
“Deep candidiasis can remain localized or spread causing a secondary infection [7].”
BackgroundEpidemiology of Invasive Candidiasis
Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology · doi:10.2147/clep.s459600 · Cited by 109
León, C., Ostrosky-Zeichner, L. L., & Schuster, M. G. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3281-0 · Cited by 118
“Approximately one-third of patients fall into each group [18, 48].”
BackgroundThe current treatment landscape: Candidiasis
Bassetti, M., Peghin, M., & Timsit, J.-F. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw392 · Cited by 99
Non-Culture Diagnostics for Invasive Candidiasis: Promise and Unintended Consequences
Clancy, C., & Nguyen, M. H. (2018) · Journal of Fungi · doi:10.3390/jof4010027 · Cited by 95
“The limit of detection depending on species is 1–3 CFU/mL, which is superior to that generally reported for PCR assays [1,20].”
BackgroundMethodInfluentialSelf-citationStrategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries
Kaur, H., & Chakrabarti, A. (2017) · Journal of Fungi · doi:10.3390/jof3030041 · Cited by 93
“Approximately 50% of candidemia cases may yield negative blood culture results [73].”
BackgroundRole of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children
Huppler, A. R., Fisher, B. T., Lehrnbecher, T., Walsh, T. J., & Steinbach, W. J. (2017) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pix054 · Cited by 93
Farmakiotis, D., Kyvernitakis, A., Tarrand, J. J., & Kontoyiannis, D. P. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.07.006 · Cited by 86
“Indeed, the high mortality associated with candidaemia in the present and previous [7,8,14] reports can be attributed to the long time that is needed for culture-based diagnosis [26].”
BackgroundAntifungal stewardship in invasive Candida infections
Ruhnke, M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12622 · Cited by 99
“Candida PCR is now regarded as the most promising tool for rapid diagnosis of IC/ C to close the ‘diagnostic gap’ [16,23].”
BackgroundMethodZhang, S. X., Babady, N. E., Hanson, K. E., Harrington, A., Larkin, P. M. K., Leal, S. M., Luethy, P. M., Martin, I. W., Pancholi, P., Procop, G. W., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.01784-20 · Cited by 90
“diasis (IC) with a sensitivity of approximately 50% (71).”
Backgroundon behalf of ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva), Giacobbe, D. R., Mikulska, M., Tumbarello, M., Furfaro, E., Spadaro, M., Losito, A. R., Mesini, A., De Pascale, G., Marchese, A., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1763-5 · Cited by 84
Mylonakis, E. E., Zacharioudakis, I. M., Clancy, C. J., Nguyen, M. H., & Pappas, P. G. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01756-17 · Cited by 84
“In studies comparing their performance with postmortem autopsy results of patients proven to have invasive candidiasis, the sensitivity of blood cultures ranged from 21 to 71% (7).”
BackgroundResultSelf-citationChen, S. C., Sorrell, T. C., Chang, C. C., Paige, E. K., Bryant, P. A., & Slavin, M. A. (2014) · Internal Medicine Journal · doi:10.1111/imj.12597 · Cited by 88
Huang, D., Ni, D., Fang, M., Shi, Z., & Xu, Z. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04649 · Cited by 82
Invasive Fungal Infections in the Intensive Care Unit
Ostrosky-Zeichner, L., & Al-Obaidi, M. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.05.005 · Cited by 76
“This combined test is approved for use in Europe but not in the United States.15 Polymerase chain reaction (PCR) is another diagnostic method to consider when available.”
BackgroundInfluentialT2 magnetic resonance for the diagnosis of bloodstream infections: charting a path forward
Clancy, C. J., & Nguyen, M. H. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky050 · Cited by 84
Self-citationAntifungal Susceptibility Testing: A Primer for Clinicians
Wiederhold, N. P. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab444 · Cited by 88
Beyda, N. D., Alam, M. J., & Garey, K. W. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.07.007 · Cited by 84
“…to other non-culture based diagnostic tests, a limitation of the T2Candida assay is the trument with T2Candida assay and automated blood culture in the //dx.doi.org/10.1016/j.diagmicrobio.2013.07.007 possibility of system contamination resulting in false-positive results (Clancy and Nguyen, 2013).”
BackgroundInfluentialRecent advances in the microbiological diagnosis of bloodstream infections
Florio, W., Morici, P., Ghelardi, E., Barnini, S., & Lupetti, A. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1407745 · Cited by 82
Segrelles‐Calvo, G., Araújo, G. R. D. S., Pastor, E. L., Carrillo, J., Hernández‐Hernández, M., Rey, L., Melean, N. R., Escribano, I., Antón, E. G., Zamarro, C., et al. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106619 · Cited by 81
“In those patients, cultures of infected tissues were performed [11].”
T2Candida for the Diagnosis and Management of Invasive Candida Infections
Monday, L., Acosta, T. J. P., & Alangaden, G. J. (2021) · Journal of Fungi · doi:10.3390/jof7030178 · Cited by 78
“Invasive candidiasis as a disease spectrum includes not only candidemia (with or without deep-seated infection), but also isolated deep-seated candidiasis without candidemia [5].”
BackgroundAzim, A., & Ahmed, A. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1256158 · Cited by 82
“Blood culture sensitivity is 50 to 95% with a turnaround time of 3 to 7 days for candidemia and is even lower for deep-seated candidiasis without candidemia (Clancy and Nguyen, 2013; Tabak et al., 2018; Fernandez et al., 2009).”
BackgroundBassetti, M., Peghin, M., Carnelutti, A., Righi, E., Merelli, M., Ansaldi, F., Trucchi, C., Alicino, C., Sartor, A., Toniutto, P., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4717-0 · Cited by 78
Candidemia in children: Epidemiology, prevention and management
Mantadakis, E., Pana, Z. D., & Zaoutis, T. E. (2018) · Mycoses · doi:10.1111/myc.12792 · Cited by 77
Novel mouse monoclonal antibodies specifically recognizing β-(1→3)-D-glucan antigen
Matveev, A. L., Krylov, V. B., Khlusevich, Y. A., Baykov, I. K., Yashunsky, D. V., Emelyanova, L. A., Tsvetkov, Y. E., Karelin, A. A., Bardashova, A. V., Wong, S. S. W., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0215535 · Cited by 68
Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children
King, J., Pana, Z. D., Lehrnbecher, T., Steinbach, W. J., & Warris, A. (2017) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pix053 · Cited by 77
“seminated infection, and deep-seated infection in the absence of candidemia [44, 45].”
BackgroundTaira, C. L., Okay, T. S., Delgado, A. F., Ceccon, M. E. J. R., de Almeida, M. T. G., & Negro, G. M. B. D. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-406 · Cited by 71
“antifungal therapy [34].”
Riera, F. O., Caeiro, J. P., Angiolini, S. C., Vigezzi, C., Rodriguez, E., Icely, P. A., & Sotomayor, C. E. (2022) · Antibiotics · doi:10.3390/antibiotics11070877 · Cited by 65
Candida biomarkers in patients with candidaemia and bacteraemia
Martínez-Jiménez, M. C., Muñoz, P., Valerio, M., Alonso, R., Martos, C., Guinea, J., & Bouza, E. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv090 · Cited by 65
Bassetti, M., Scudeller, L., Giacobbe, D. R., Lamoth, F., Righi, E., Zuccaro, V., Grecchi, C., Rebuffi, C., Akova, M., Alastruey‐Izquierdo, A., et al. (2019) · Mycoses · doi:10.1111/myc.12869 · Cited by 64
Molecular Methods for the Diagnosis of Invasive Candidiasis
Camp, I., Spettel, K., & Willinger, B. (2020) · Journal of Fungi · doi:10.3390/jof6030101 · Cited by 75
“Even though blood cultures (BC) are sensitive at detecting viable Candida cells, with a limit of detection of one colony forming unit (CFU)/mL, their overall sensitivity across the spectrum of IC is only 50%, and they have a lag time for identification of up to 5 days [38,39].”
BackgroundKeighley, C., Cooley, L., Morris, A. J., Ritchie, D., Clark, J. E., Boan, P., & Worth, L. J. (2021) · Internal Medicine Journal · doi:10.1111/imj.15589 · Cited by 74
Martínez-Jiménez, M. C., Muñoz, P., Valerio, M., Vena, A., Guinea, J., & Bouza, E. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv241 · Cited by 64
Jia, X., Li, C., Cao, J., Wu, X., & Zhang, L. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3304-9 · Cited by 66
“In addition, blood cultures are regarded as the gold standard for diagnosing candidemia, but this method suffers from delayed results, and nearly half of cases go undetected [6].”
Emerging methodologies for pathogen identification in positive blood culture testing
Dubourg, G., & Raoult, D. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1112274 · Cited by 71
“[46] T2 Candida Panel has proven an added value in detection of invasive candidiasis such as deep seated infection without peripheral candidemia.[47] Pfaller et al.”
BackgroundT2Candida Provides Rapid and Accurate Species Identification in Pediatric Cases of Candidemia
Hamula, C. L. A., Hughes, K., Fisher, B. T., Zaoutis, T. E., Singh, I. R., & Velegraki, A. (2016) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqw063 · Cited by 61
Muñóz, P., Vena, A., Machado, M., Gioia, F., Martínez‐Jiménez, M. D. C., Gómez, E., Origüen, J., Orellana, M. Á., López‐Medrano, F., Fernández‐Ruiz, M., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky047 · Cited by 65
Neonatal invasive candidiasis: updates on clinical management and prevention
Kilpatrick, R., Scarrow, E. R., Hornik, C., & Greenberg, R. G. (2021) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(21)00272-8 · Cited by 69
Gold, J. A. W., Ahmad, F. B., Cisewski, J. A., Rossen, L. M., Montero, A. J., Benedict, K., Jackson, B. R., & Toda, M. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciac489 · Cited by 60
Ding, L., Xia, R., Zhang, Q., Bai, C., Li, Z., & Zhang, P. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2636-x · Cited by 67
Failure of Empirical Systemic Antifungal Therapy in Mechanically Ventilated Critically Ill Patients
Bailly, S., Bouadma, L., Azoulay, É., Garrouste-Orgeas, M., Adrie, C., Souweine, B., Schwebel, C., Maubon, D., Hamidfar-Roy, R., Darmon, M., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201409-1701oc · Cited by 63
Serious fungal infections in Pakistan
Jabeen, K., Farooqi, J. Q., Mirza, S., Denning, D. W., & Zafar, A. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2919-6 · Cited by 74
“Furthermore, candidaemia is only a subset of all patients with invasive candidiasis, as blood cultures are only about 38% sensitive [41, 42].”
BackgroundMicrofluidic Chip for Detection of Fungal Infections
Asghar, W., Sher, M., Khan, N. S., Vyas, J. M., & Demirci, U. (2019) · ACS Omega · doi:10.1021/acsomega.9b00499 · Cited by 64
Pre-clinical Imaging of Invasive Candidiasis Using ImmunoPET/MR
Morad, H. O. J., Wild, A., Wiehr, S., Davies, G. E., Maurer, A., Pichler, B. J., & Thornton, C. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01996 · Cited by 71
“Previous studies using a mouse model of IC demonstrated in vivo muscle infection caused by C. albicans (Oblack et al., 1980), while infection of the colon by C. albicans during IC has been shown both in mouse infection models and in humans (Cole et al., 1996; Praneenararat, 2014).”
ResultCamargo, J. F., Ahmed, A. A., Lindner, M. S., Morris, M. I., Anjan, S., Anderson, A. D., Prado, C. E., Dalai, S. C., Martínez, O., & Komanduri, K. V. (2020) · F1000Research · doi:10.12688/f1000research.19766.4 · Cited by 62
Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients
Bays, D. J., & Thompson, G. R. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2019.02.006 · Cited by 61
The Economic Impact of Rapid Candida Species Identification by T2Candida Among High-Risk Patients
Bilir, S. P., Ferrufino, C. P., Pfaller, M. A., & Munakata, J. (2015) · Future Microbiology · doi:10.2217/fmb.15.29 · Cited by 58
Abid, F. B., Salah, H., Sundararaju, S., Dalil, L., Abdelwahab, A. H., Salameh, S., Ibrahim, E. B., Almaslmani, M. A., Tang, P., Pérez‐López, A., et al. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.04.025 · Cited by 59
The Emerging Threat of Antifungal Resistance in Transplant Infectious Diseases
Schwartz, I. S., & Patterson, T. F. (2018) · Current Infectious Disease Reports · doi:10.1007/s11908-018-0608-y · Cited by 57
Diagnosis and Treatment of Candidemia in the Intensive Care Unit
Bassetti, M., Giacobbe, D. R., Vena, A., & Wolff, M. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1693704 · Cited by 72
Garvey, M., Meade, E., & Rowan, N. J. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.158284 · Cited by 64
Amphotericin B in the Era of New Antifungals: Where Will It Stand?
Akinosoglou, K., Rigopoulos, E. A., Papageorgiou, D., Schinas, G., Polyzou, E., Dimopoulou, E., Gogos, C. A., & Dimοpoulos, G. (2024) · Journal of Fungi · doi:10.3390/jof10040278 · Cited by 68
“Cultures diagnose less than 50% of patients with invasive candidiasis [60] and invasive Fusarium infections [61], while they perform less well for deep-seated infections [62].”
BackgroundPotential role of Candida albicans germ tube antibody in the diagnosis of deep-seated candidemia
Martínez‐Jiménez, M. D. C., Muñóz, P., Guinea, J., Valerio, M., Alonso, R., Escribano, P., & Bouza, E. (2014) · Medical Mycology · doi:10.1093/mmy/myt025 · Cited by 56
“Patients with candidemia may have transient or catheterrelated infections without involvement of deep tissues or deep-seated candidiasis [1,2].”
Background
Metadata
- Authors
- Clancy, C. J., & Nguyen, M. H.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Clancy, Cornelius J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01-11
- Volume
- 56
- Issue
- 9
- Pages
- 1284-1292
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2113002556
- Semantic Scholar
- 09ab621e4fddac8144b07f459f06bc7901d0d1bd
- Cited by
- 688
- References
- 39
- Citations by year
- 2026: 36 · 2025: 56 · 2024: 55 · 2023: 60 · 2022: 59 · 2021: 68 · 2020: 56 · 2019: 66 · 2018: 60 · 2017: 54 · 2016: 52 · 2015: 32 · 2014: 26 · 2013: 8
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- invasive candidiasis, beta-D-glucan assay, sensitivity and specificity, positive predictive value, negative predictive value, antifungal therapy, disease spectrum, biomarkers
- MeSH terms
- DNA, Fungal, Patient Care, Humans, Predictive Value of Tests, Sensitivity and Specificity, Biomarkers, Clinical Laboratory Techniques, beta-Glucans, Candidiasis, Invasive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.